{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:24:50Z","timestamp":1786119890136,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4,24]]},"DOI":"10.1097\/qad.0b013e3283466f85","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T06:22:56Z","timestamp":1302589376000},"page":"1006-1009","source":"Crossref","is-referenced-by-count":10,"title":["The use of atazanavir in HIV-infected patients with liver cirrhosis: lack of hepatotoxicity and no significant changes in bilirubin values or model for end-stage liver disease score"],"prefix":"10.1097","volume":"25","author":[{"given":"Jose M","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M","family":"Hermida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose L","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Quereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Dronda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Hernandez-Novoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J","family":"Perez-Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210130","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.21757","article-title":"Clinical rogression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy","volume":"46","author":"Pineda","year":"2007","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"R2-16-20210130","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1086\/381447","article-title":"Liver toxicity in epidemiological cohorts","volume":"38","author":"Becker","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R3-16-20210130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0163-4453(03)00067-7","article-title":"Hepatitis C virus and human immunodeficiency virus coinfection in Spain","volume":"47","author":"Roca","year":"2003","journal-title":"J Infect"},{"key":"R4-16-20210130","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1086\/427216","article-title":"Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection","volume":"40","author":"Aranzabal","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R5-16-20210130","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01.aids.0000166091.39317.99","article-title":"Atazanavir plus ritonavir or saquinavir, and lopinavir\/ritonavir in patients experiencing multiple virological failures","volume":"19","author":"Johnson","year":"2005","journal-title":"AIDS"},{"key":"R6-16-20210130","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/520092","article-title":"Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients","volume":"196","author":"Labarga","year":"2007","journal-title":"J Infect Dis"},{"key":"R7-16-20210130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/jac\/dkn045","article-title":"Liver toxicity of antiretroviral combinations including atazanavir\/ritonavir in patients co-infected with HIV and hepatitis viruses: impact of preexisting liver fibrosis","volume":"61","author":"Pineda","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"R8-16-20210130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s15010-008-8025-z","article-title":"Efficacy and safety of atazanavir in patients with end-stage liver disease","volume":"37","author":"Guaraldi","year":"2009","journal-title":"Infection"},{"key":"R9-16-20210130","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1310\/hct1004-269","article-title":"Short-term effect of ritonavir-boosted atazanavir in hepatitis B and\/or C co-infected, treatment-experienced HIV patients","volume":"10","author":"Perez-Elias","year":"2009","journal-title":"HIV Clin Trials"},{"key":"R10-16-20210130","first-page":"30","article-title":"Report from the 17th Conference on Retroviruses and Opportunistic Infections. More data and answers from ACTG 5202","volume":"22","author":"Henry","year":"2010","journal-title":"AIDS Clin Care"},{"key":"R11-16-20210130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0140-6736(08)61081-8","article-title":"Once-daily atazanavir\/ritonavir versus twice-daily lopinavir\/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study","volume":"372","author":"Molina","year":"2008","journal-title":"Lancet"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e3283466f85","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:16:30Z","timestamp":1786043790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201104240-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,24]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3283466f85","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4,24]]}}}